Zimbabwe has turned down a major American healthcare agreement worth $367m (272 million pounds) over five years due to Washington's insistence on sensitive biological samples.
The decision came to light after a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government spokesman has since stated that the United States was requesting health data for research and commercial purposes but was unwilling to share the resulting advantages from any future treatments.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for further dialogue to secure a agreement acceptable to both sides so the country's critical HIV treatment initiative can be sustained.
Wider Background
This rejection follows a comparable case in Kenya, where a court suspended a related health funding agreement after legal challenges were raised about the security of Kenyans' medical information.
Since resuming the presidency last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government deals to boost transparency and accountability.
Based on statements, Sixteen African countries have to date signed these new agreements, representing more than $18.3bn in new funding.
Details of the Declined Agreement
The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment through American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information over an extended period, with no corresponding guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"Effectively, our nation would provide the raw materials for scientific discovery with no assurance that the end products would be available to our people should a future pandemic arise."
Sovereignty and Global Health
He also noted that the American exit from the global health body and its pursuit of one-on-one deals were undermining frameworks previously set up through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.
"This framework is designed to guarantee that when a country provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We encourage further dialogue with our American counterparts on how subsequent collaboration could be designed in a manner that honours the independence and dignity of both nations."
Medical Community Reaction
A leading public health body expressed it understood the official position, but suggested that talks need to persist considering much of the nation's Aids initiatives were funded by external financing.
"In cases where technical issues arise, such as those relating to data governance or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it said.
The halted deal emphasises the ongoing tensions between receiving much-needed international aid and safeguarding a country's data in an increasingly data-driven world.